Vsee Health, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
VSEE Health's CFO, Jerry Leonard, acquired common stock through quarterly equity awards, resulting in a net change in his beneficial ownership.
NASDAQ
VSEE Health's Co-CEO, Imoigele Aisiku, increased beneficial ownership by 288,410 shares through quarterly equity awards, reflecting a significant decline in the company's stock price during 2025.
NASDAQ
VSEE Health, Inc. Director Colin P. O'Sullivan acquired 40,107 shares of common stock at $0.374 per share, increasing his direct beneficial ownership to 108,731 shares.
NASDAQ
VSEE Health Director Scott Metzger acquired 40,107 shares of common stock as compensation for services rendered, increasing his direct beneficial ownership to 117,356 shares.
NASDAQ
VSEE Health Director Kevin Lowdermilk acquired 40,107 shares of common stock as part of his compensation for Q4 2025 services.
NASDAQ
VSEE Health Director David L. Wickersham acquired 40,107 shares of common stock as part of his compensation for services.
NASDAQ
VSEE Health Director David L. Wickersham converted convertible promissory notes into common stock, significantly increasing his indirect beneficial ownership.
NASDAQ
VSEE Health Director David L. Wickersham acquired 100,000 shares of common stock valued at $2 per share from Co-CEO Imoigele Aisiku to settle a $200,000 personal loan.
NASDAQ
VSEE Health, Inc.'s Co-Chief Executive Officer, Imoigele Aisiku, reported the disposal of 125,000 common shares to satisfy personal loans.
NASDAQ
VSEE Health, Inc. Director David L. Wickersham acquired 68,397 shares of common stock through routine compensation for services.
NASDAQ
VSEE Health director Scott Metzger acquired 68,624 shares of common stock as compensation for services rendered across multiple quarters.
NASDAQ
VSEE Health Director Kevin Lowdermilk has disclosed the anticipated acquisition of 68,624 shares of common stock through the company's 2024 Incentive Plan as future compensation for services.
NASDAQ
VSEE Health, Inc. Director Colin P. O'Sullivan acquired a total of 68,624 common shares through multiple issuances under the company's 2024 Incentive Plan for director services.
NASDAQ
VSEE Health, Inc. director Cydonii V. Fairfax reported the acquisition of 68,397 shares of common stock through multiple grants for director services.
NASDAQ
VSee Health's Chief Financial Officer, Jerry Leonard, reported multiple acquisitions of common stock totaling 560,724 shares, including a retention bonus and compensation for past services.
NASDAQ
Digital Health Sponsor LLC and its manager, Lawrence M. Sands, reported a pro rata distribution of VSEE Health, Inc. common stock, Series A Preferred Stock, and warrants to its members for no consideration.
NASDAQ
VSEE Health Co-CEO Imoigele Aisiku reported a transfer of 120,000 common shares, leaving him with 3,416,990 shares.
NASDAQ
Lawrence M. Sands, a director of VSEE Health, Inc., acquired 202,500 shares of common stock through an agreement with SCS, LLC.
NASDAQ
Lawrence Sands, a director and 10% owner of VSEE Health, Inc., reports acquiring 2,500 shares of common stock through an agreement with SCS, LLC.
NASDAQ
Digital Health Sponsor LLC reports acquisition of common stock, preferred stock, and warrants in VSee Health, Inc. following a business combination.
NASDAQ
Lawrence Sands, a director and 10% owner of VSEE Health, Inc., reported the acquisition of Series A preferred stock and indirect ownership of common stock following a business combination.
NASDAQ
Milton Chen, Co-CEO of VSEE Health, reports acquiring 2,870,069 shares of common stock as a result of the company's recent business combination.
NASDAQ
Co-CEO Imoigele Aisiku reports receiving 3,536,990 shares of VSEE Health common stock following the completion of a business combination.